News

Caremark was found liable in June, and Philadelphia federal court Chief Judge Mitchell Goldberg ordered the company to pay $95 million in damages, deferring final rulings on penalties.
A federal judge has ordered CVS Caremark to pay almost $290 million in damages and penalties after a whistleblower proved the ...
Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the ...
A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...
In this final video of a three-part video series, Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and a winner of Managed Healthcare Executive’s PBMI Innovator Award, said most health ...
California’s health care purchaser expects to save $600 million over the five-year contract with CVS Caremark.
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those with previous adverse reactions.
Caremark claims, which challenge failures to act rather than affirmative actions, could be brought against a company's board of directors, but the bar for liability was high.
Starting July 1, CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed ...
Caremark’s other units also are growing fast, said O’Neil, and as a result, he is predicting the company will show growth of between 20 and 25 percent each year for the next few years.
Caremark was the fourth-most active issue, gaining 75 cents to close at $29.50, on 5.7 million shares traded. Several analysts said the deal makes sense, in terms of timing, strategy, value and ...
Specifically, the Caremark doctrine was returned to potency in 2019 following the Delaware Supreme Court's decision in Marchand v. Barnhill, 212 A.3d 805 (Del. 2019). Although Marchand did not ...